What is BioSig Technologies, Inc.'s US — cash?

BioSig Technologies, Inc. (STEX) reported US — cash of $1.95M in Q1 2026.

What does US — cash mean?

This metric measures the total amount of cash and cash equivalents held within the United States segment, including liquid reserves and operational funds. It provides insight into the liquidity position available to support domestic business activities, capital expenditures, or immediate debt obligations. A robust cash position in this segment indicates operational flexibility and the ability to fund U.S.-based growth initiatives without external financing.

BioSig Technologies, Inc. STEX US — Cash

Other geography segments

$4.91M—

Similar metrics at other companies

GENU.S. — Cash, cash equivalents and restricted cash

$216M—

ISPRUS — Cash

$152.35K—

KBRU.S — Cash & Equivalents

$135M+70.9%

MHKNon-US — Cash and Cash Equivalent

$370.8M+104%

INODUS — Cash And Cash Equivalents At Carrying Value

$101.4M+158%

SESNon Us — Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

$27.9M+534%

Other financials

Income statement

See full

Revenue$13.0K+8.3%

Gross profit$12.0K-88.9%

Operating income-$35.7M-1,098%

Net income-$46.7M-1,560%

EPS (diluted)-$0.27-92.9%

Balance sheet

See full

Cash & equivalents$6.9M+84.0%

Total debt$15.0K-94.7%

Total equity$159.0M+6,003%

Total assets$173.3M+3,823%

Cash flow

See full

Operating cash flow-$10.2M-813%

CapEx$4.0K-93.1%

Free cash flow-$2.9M+29.4%

Valuation

See full

Market cap$88.66M-61.8%

P/S2,216.6×-5,967×

Profitability

See full

Gross margin80.1%+25.2pp

Operating margin-32,155%-14,261pp

Net margin-25,825%-11,789pp

FCF margin-97,216.7%-106,293pp

Returns & leverage

See full

Return on equity-627.1%—

Debt / equity0×—

Current ratio13.9×+11.5×

Where this comes from

Reported directly by BioSig Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Cash.

The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioSig Technologies, Inc.'s us — cash.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioSig Technologies, Inc.'s US — cash?: BioSig Technologies, Inc. (STEX) reported US — cash of $1.95M in Q1 2026.
What does US — cash mean?: This metric measures the total amount of cash and cash equivalents held within the United States segment, including liquid reserves and operational funds. It provides insight into the liquidity position available to support domestic business activities, capital expenditures, or immediate debt obligations. A robust cash position in this segment indicates operational flexibility and the ability to fund U.S.-based growth initiatives without external financing.